Nanoparticles for immunotherapy

Nanoparticles that activate complement in the absence of biological molecules are described. The nanoparticles are shown to specifically target antigen presenting cells in specifically in lymph nodes, without the use of a biological molecule for targeting. These particles are useful vehicles for delivering immunotherapeutics. Surface chemistries and chemical formulations for the nanoparticles are described.


Year:
2010
Other identifiers:
TTO: 6.0843
EPO Family ID: 41722294
Laboratories:




 Record created 2015-09-22, last modified 2018-01-27


Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)